Elanco Animal Health, Inc. (ELAN)
23.92
+0.38
(+1.61%)
USD |
NYSE |
Oct 16, 09:54
Elanco Animal Health SG&A Expense (TTM) : 1.519B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.519B |
| March 31, 2026 | 1.47B |
| December 31, 2025 | 1.43B |
| September 30, 2025 | 1.392B |
| June 30, 2025 | 1.364B |
| March 31, 2025 | 1.318B |
| December 31, 2024 | 1.314B |
| September 30, 2024 | 1.306B |
| June 30, 2024 | 1.296B |
| March 31, 2024 | 1.295B |
| December 31, 2023 | 1.285B |
| September 30, 2023 | 1.296B |
| June 30, 2023 | 1.281B |
| March 31, 2023 | 1.271B |
| December 31, 2022 | 1.267B |
| September 30, 2022 | 1.291B |
| June 30, 2022 | 1.335B |
| Date | Value |
|---|---|
| March 31, 2022 | 1.377B |
| December 31, 2021 | 1.402B |
| September 30, 2021 | 1.449B |
| June 30, 2021 | 1.385B |
| March 31, 2021 | 1.163B |
| December 31, 2020 | 996.60M |
| September 30, 2020 | 808.40M |
| June 30, 2020 | 723.00M |
| March 31, 2020 | 761.10M |
| December 31, 2019 | 760.20M |
| September 30, 2019 | 759.40M |
| June 30, 2019 | 746.10M |
| March 31, 2019 | 736.30M |
| December 31, 2018 | 735.20M |
| September 30, 2018 | 550.10M |
| June 30, 2018 | 371.10M |
| March 31, 2018 | 180.00M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Zoetis, Inc. | 2.378B |
| ANI Pharmaceuticals, Inc. | 324.76M |
| Eli Lilly & Co. | 12.24B |
| Corcept Therapeutics, Inc. | 556.47M |
| Veru, Inc. | 16.05M |